• Ultrasound Renal Denervation
    • About Hypertension
    • Paradise Ultrasound RDN System
    • Clinical Evidence
    • Patient selection
    • Publications
  • Resources
    • TPT Resources
    • Reimbursement Resources
    • National Coverage Determination
    • Educational Resources
    • Hospital PR Materials
  • About Recor
    • Our Story
    • Our Values
    • Management
    • Idea Portal
    • Product Feedback
    • ISR & Grants
    • Careers
  • News
    • Press Releases
  • Ultrasound Renal Denervation
    • About Hypertension
    • Paradise Ultrasound RDN System
    • Clinical Evidence
    • Patient selection
    • Publications
  • Resources
    • TPT Resources
    • Reimbursement Resources
    • National Coverage Determination
    • Educational Resources
    • Hospital PR Materials
  • About Recor
    • Our Story
    • Our Values
    • Management
    • Idea Portal
    • Product Feedback
    • ISR & Grants
    • Careers
  • News
    • Press Releases

For Patients | EU Site

Connect

Corporate Governance

California Compliance Statement

California Proposition 65

Social Media Community Guidelines


Code of Business Ethics

Otsuka Holdings Co., Ltd.

Privacy Policy  |  Applicant Contract Worker and Former Employee Privacy Policy  |  Business Contact Privacy Policy Terms & Conditions  |  Connect  |  Corporate Governance  |  Patents 

Follow us on:

Twitter Youtube Linkedin

© 2025 Recor Medical, Inc. All rights reserved. The Paradise uRDN system is FDA approved for sale in the United States, is CE marked and approved for sale in markets where the CE mark is accepted per approved indications for use, and received manufacturing and marketing approval in Japan. RECOR MEDICAL, PARADISE, HYDROCOOLING, SONOWAVE 360, RADIANCE, the GPS logo, and the Swirl logo are registered trademarks in the EU and the other countries, RECOR and the RADIANCE logo are also trademarks of Recor Medical, Inc.